Martin Bergmann

Showing 1-13 of 13 articles

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou C, Özdemir R, Pfister R, Bergmann M, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker S, Sievert H, Mahfoud F

August 29, 2019 | 10.4244/EIJ-D-19-00342

European registry data on LAA closure: advancing the field of interventional stroke prevention

Bergmann M

June 20, 2018 | 10.4244/EIJV14I2A20

Interventions for stroke

Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study

Bergmann M, Ince H, Kische S, Schmitz T, Meincke F, Schmidt B, Foley DP, Betts TR, Grygier M, Protopopov A, Stein KM, Boersma L

April 20, 2018 | 10.4244/EIJ-D-17-00672

Interventions for stroke

Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry

Bergmann M, Betts TR, Sievert H, Schmidt B, Pokushalov E, Kische S, Schmitz T, Meincke F, Stein KM, Boersma L, Ince H

September 20, 2017 | 10.4244/EIJ-D-17-00042

Interventions for stroke

Left atrial appendage closure: patient, device and post-procedure drug selection

Tzikas A, Bergmann M

May 16, 2016 | 10.4244/EIJV12SXA10

Coronary interventions

Safety and efficacy of lesion preparation with the AngioSculpt Scoring Balloon in left main interventions: the ALSTER Left Main registry

Schmidt T, Hansen S, Meincke F, Frerker C, Kuck K, Bergmann M

March 18, 2016 | 10.4244/EIJY15M05_04

Coronary interventions

Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry

Heeger C-H, Busjahn A, Hildebrand L, Fenski M, Lesche F, Meincke F, Kuck K, Bergmann M

January 20, 2016 | 10.4244/EIJY14

Twelve-month results of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot™ Ablation System (RAPID) study

Verheye S, Ormiston J, Bergmann M, Sievert H, Schwindt A, Werner N, Vogel B, Colombo A

February 20, 2015 | 10.4244/EIJY14M12_02

Percutaneous left atrial appendage closure in patients with left atrial appendage thrombus

Meincke F, Kreidel F, Von Wedel J, Schäfer U, Kuck K, Bergmann M

February 20, 2015 | 10.4244/EIJV10I10A199

Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques

Bergmann M, Landmesser U

August 19, 2014 | 10.4244/EIJV10I4A86

Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system

Kaiser L, Beister T, Wiese A, Von Wedel J, Meincke F, Kreidel F, Busjahn A, Kuck K, Bergmann M

May 20, 2014 | 10.4244/EIJV10I1A24

New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN® device in patients not taking warfarin

Meincke F, Schmidt-Salzmann M, Kreidel F, Kuck K, Bergmann M

August 23, 2013 | 10.4244/EIJV9I4A75

Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial

Heeger C-H, Jaquet K, Thiele H, Zulkarnaen Y, Cuneo A, Haller D, Kivelitz D, Schmidt T, Krause K, Metzner A, Schneider C, Kuck K, Bergmann M

October 26, 2012 | 10.4244/EIJV8I6A113

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...